Prestige Consumer Healthcare
336 hedge funds and large institutions have $4.1B invested in Prestige Consumer Healthcare in 2024 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 126 increasing their positions, 110 reducing their positions, and 28 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
46% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 28
15% more repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 110
11% more capital invested
Capital invested by funds: $3.68B → $4.1B (+$413M)
3.18% more ownership
Funds ownership: 103.04% → 106.23% (+3.2%)
2% more funds holding
Funds holding: 328 → 336 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$84.4M |
| 2 |
Bessemer Group
Woodbridge,
New Jersey
|
+$22.7M |
| 3 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$19.6M |
| 4 |
BlackRock
New York
|
+$18.5M |
| 5 |
Natixis Advisors
Boston,
Massachusetts
|
+$15.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$31.5M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$28.4M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$10M |
| 4 |
Neuberger Berman Group
New York
|
-$9.44M |
| 5 |
Jennison Associates
New York
|
-$9.11M |
PBH Hedge Fund Activity: Q4 2024 in Review
336 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q4 2024, worth a combined $4.1B — up 11% from $3.68B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new PBH positions and 28 closed out — a net gain of 13 holders — while 126 added to existing stakes and 110 trimmed.
The largest buyer was Kayne Anderson Rudnick Investment Management, opening a new position worth an estimated $84.4M. The largest seller was Victory Capital Management, cutting an estimated $31.5M.
- 336 institutional investors held Prestige Consumer Healthcare (PBH) as of Q4 2024, up from 328 in Q3 2024.
- Funds reported $4.1B of Prestige Consumer Healthcare stock for Q4 2024, up 11% quarter-over-quarter.
- 41 funds opened new Prestige Consumer Healthcare positions in Q4 2024 and 28 closed out, a net change of +13 holders.
- The largest Prestige Consumer Healthcare buyer in Q4 2024 was Kayne Anderson Rudnick Investment Management, an estimated $84.4M added.
- The largest Prestige Consumer Healthcare seller in Q4 2024 was Victory Capital Management, an estimated $31.5M sold.
Based on aggregated 13F filings for Q4 2024.